Yang Jun

Dr. Yang Jun’s work centers on non-invasive precision radiotherapy, with Fosun Health describing him as a CyberKnife expert with 6,000+ treatment cases. As Director of the Precision Oncology Centre at Foshan Chancheng Hospital (Fosun Hospital Foshan), he is presented as personally reviewing patient cases during consultations. Fosun Health promoted a free one-on-one cancer consultation with Dr. Yang Jun in Jakarta on June 18, 2026, and the outreach materials emphasized “no surgery” and “no incision” options. Beyond CyberKnife practice, Fosun Health news notes that his Oncology Center team’s research on Stereotactic Central Ablative Radiotherapy (SCART) was selected for a Featured Presentation at an upcoming Global RSS meeting (2026-01-23).

Education

Formal education details are not provided in the available materials.

Work experience

• Director, Precision Oncology Centre — Foshan Chancheng Hospital (Fosun Hospital Foshan).
• CyberKnife expert / medical physics — Foshan Chancheng Hospital (as described by Fosun Health).

Clinical focus and techniques

Fosun Health describes Dr. Yang Jun’s clinical scope as precision oncology delivered with non-invasive radiotherapy technologies.

• CyberKnife — robotic stereotactic radiosurgery/radiotherapy for cancer.
• Stereotactic Central Ablative Radiotherapy (SCART) — presented through his team’s research and presentations.

Professional societies and certifications

No society certifications are listed in the provided materials.

Academic output

Academic publication metrics are not listed in the provided materials.

Courses and advanced training

• Featured Presentation selection for SCART research at an upcoming Global RSS meeting (2026-01-23).

Awards and recognition

Awards are not listed in the provided materials.

Fosun Health’s international outreach for Dr. Yang Jun includes Jakarta (June 18, 2026) and Tangerang seminar events, with case review offered during the consultation. His practice is described for cancers including brain, lung, liver, prostate, and spine, using CyberKnife-based non-invasive treatment pathways.